In this issue:
Biologic drug survival rates with anti-IL-17 antibodies
Small molecule inhibitors and biologics for nail psoriasis
Combination treatment with methotrexate and TNF-α antagonists
IL-17 and cytokines in recalcitrant psoriasis after ustekinumab
Nemolizumab for AD
Dupilumab in Asian children and adolescents with AD
Tralokinumab effect on vaccine-induced immune responses
Immune profiling of lupus miliaris disseminatus faciei
Please login below to download this issue (PDF)